Scribe Therapeutics
Anthony Mauriello has worked at three different companies since 2018. Anthony started as an Undergraduate Research Assistant at the University of California, Berkeley in 2018, and also worked as an Undergraduate Lab Course Intern, assisting a graduate student in teaching an undergraduate lab course. In 2018, they also worked as a Summer Intern at FLX Bio, Inc. In 2020, they began working at Scribe Therapeutics as a Research Specialist and a Summer Intern.
Anthony Mauriello attended the University of California, Berkeley from 2017-2021.
Scribe Therapeutics
1 followers
Scribe is focused on the engineering, delivery, and development of next-generation CRISPR molecules to rewrite and repair the underlying cause of genetic disorders.